Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists
BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists
BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists
Submitted by
admin
on December 6, 2016 - 10:05pm
Source:
Medical Marketing and Media
News Tags:
Boehringer Ingelheim
Eli Lilly
cardiologists
diabetes
Jardiance
Headline:
BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists
Do Not Allow Advertisers to Use My Personal information
